Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome

NCT04219280 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.

NCT NCT04219280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 2, 2020
Completion date
August 31, 2026
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, down syndrome